On July 28, 2021, Thermo Fisher Scientific (hereinafter referred to as Thermo Fisher), the world leader in the field of scientific services, signed a memorandum of cooperation with the Management Committee of Suzhou High Tech Zone, announcing that it would invest in the construction of another brand-new factory under Thermo Fisher China manufacturing center in Suzhou High Tech Zone. The new plant will produce in vitro diagnosis and biopharmaceutical related products. After completion, it will become the largest life science industry base in Thermo Fisher Asia Pacific region. The total investment is $50 million, which is expected to be completed and put into use in 2022.

Based on the long-term friendly cooperation between Thermo Fisher and Suzhou High Tech Zone in the field of life science industry, the new factory of Thermo Fisher China manufacturing center in Suzhou planned to be invested in this time will focus on providing product and technical support for life science, biopharmaceutical, in vitro diagnosis and other industries that the state focuses on developing according to the 14TH five year plan and the strategy of "healthy China 2030". The new factory in Suzhou, after construction, will cooperate with the original factory to provide services to local customers, improve localized innovation and production capacity, and promote the healthy and rapid growth of regional industrial ecology.

Han Pang, President of Thermo Fisher China, said: the Yangtze River Delta is one of the regions with the most active economic development, the highest degree of openness and the strongest innovation ability in China. Thanks to Suzhou municipal government's long-term and vigorous promotion of the ecological construction of life science industry, Thermo Fisher` s continuous investment in Suzhou has achieved successful results. The planned investment in the new Suzhou plant will further improve the localization development strategy rooted in China and serving China", integrate into China's life science industry ecology and help the construction of precision medicine in China.

Li Yaping, deputy secretary of Suzhou municipal Party committee and mayor, said: the biomedical industry is one of the strategic emerging industries and advanced manufacturing clusters that Jiangsu Province focuses on developing. It is the "No. 1 industry" that Suzhou is trying to build. Over the past few years, focusing on the important strategic layout of "taking root in China and serving China", Thermo Fisher has deeply cultivated Suzhou and continued to increase its weight, so as to continuously inject vitality and create new opportunities for the development of Suzhou biomedical industry. In the future, Suzhou will further seize the strategic opportunity for the integrated development of the Yangtze River Delta, create a more open, inclusive and shared investment environment, attract more enterprises to invest in Suzhou, and jointly build a new landmark of the biomedical industry.

In recent years, Suzhou municipal government has made great efforts to build a world-class biomedical highland. With world-class industrial supporting services and excellent ecological innovation vitality, it has attracted Thermo Fisher 's long-term investment. Thermo Fisher has actively participated in the construction of Suzhou biomedical industry for many years and is committed to providing stable supply and leading technical support for Chinese partners to achieve large-scale production of precision medicine. In the future, the company will actively work with local customers and partners to promote the vigorous development of China's life science and biomedical industry and make the world healthier, cleaner and safer.